Neoadjuvant phase II trial of chemo-radiotherapy (CRT) in patients with resectable (R) and borderline resectable (BR) pancreatic ductal adenocarcinoma (PDA)

被引：1
|
作者：
Damarla, V. [1 ]
Dobrosotskaya, D. [1 ]
Siddiqui, F. [2 ]
Wollner, I. [1 ]
Raoufi, M. [4 ]
Li, J. [5 ]
Kwon, D. [3 ]
Khan, G. [1 ]
机构：
[1] Henry Ford Hlth Syst, Dept Med Oncol, Detroit, MI USA
[2] Henry Ford Hlth Syst, Dept Radiat Oncol, Detroit, MI USA
[3] Henry Ford Hlth Syst, Dept Surg Oncol, Detroit, MI USA
[4] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI USA
[5] Henry Ford Hlth Syst, Dept Biostat, Detroit, MI USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 92卷
关键词：
D O I：
10.1016/j.ejca.2018.01.110
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P11
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [1] A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Keiichi Okano
    Hironobu Suto
    Minoru Oshima
    Eri Maeda
    Naoki Yamamoto
    Keitaro Kakinoki
    Hideki Kamada
    Tsutomu Masaki
    Shigeo Takahashi
    Toru Shibata
    Yasuyuki Suzuki
    Annals of Surgical Oncology, 2017, 24 : 2777 - 2784
  • [2] A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Okano, Keiichi
    Suto, Hironobu
    Oshima, Minoru
    Maeda, Eri
    Yamamoto, Naoki
    Kakinoki, Keitaro
    Kamada, Hideki
    Masaki, Tsutomu
    Takahashi, Shigeo
    Shibata, Toru
    Suzuki, Yasuyuki
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2777 - 2784
  • [3] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
  • [4] Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kaufmann, Benedikt
    Hartmann, Daniel
    D'Haese, Jan G.
    Stupakov, Pavel
    Radenkovic, Dejan
    Gloor, Beat
    Friess, Helmut
    DIGESTIVE SURGERY, 2019, 36 (06) : 455 - 461
  • [5] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    Alvarez, R.
    Ales, I.
    Diaz, R.
    de Paredes, B. G.
    Hidalgo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1193 - 1198
  • [6] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    R. Álvarez
    I. Alés
    R. Díaz
    B. G. de Paredes
    M. Hidalgo
    Clinical and Translational Oncology, 2017, 19 : 1193 - 1198
  • [7] Efficacy of Neoadjuvant Chemotherapy and Radiation in Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Eastburg, Benjamin
    Frisch, Austin
    Khan, Mariam
    Wright, Gerald P.
    Assifi, Mura
    Chandra, Sreenivasa
    Chung, Mathew
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S176 - S177
  • [8] Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma
    Takaori, Ayaka
    Hashimoto, Daisuke
    Ikeura, Tsukasa
    Ito, Takashi
    Nakamaru, Koh
    Masuda, Masataka
    Nakayama, Shinji
    Yamaki, So
    Yamamoto, Tomohisa
    Fujimoto, Kosuke
    Matsuo, Yoshiyuki
    Akagawa, Shohei
    Ishida, Mitsuaki
    Yamaguchi, Kiyoshi
    Imoto, Seiya
    Hirota, Kiichi
    Uematsu, Satoshi
    Satoi, Sohei
    Sekimoto, Mitsugu
    Naganuma, Makoto
    PANCREATOLOGY, 2023, 23 (04) : 367 - 376
  • [9] Neoadjuvant therapy duration and outcome of patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (PDAC).
    Shahda, Safi
    Perkins, Susan
    Cramer, Harvey M.
    House, Michael Garrett
    Nakeeb, Attila
    Zyromski, Nicholas J.
    Ceppa, Eugene P.
    Sehdev, Amikar
    Akisik, Fatih
    Lin, Jingmei
    Schmidt, Christian
    Ellsworth, Susannah G.
    O'Neil, Nina
    Link, Kristen
    O'Neil, Bert
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [10] Neoadjuband Chemo-radiotherapy (NACRT) for Borderline Resectable Pancreatic Cancer
    Kawaguchi, M.
    Takori, K.
    Nakamura, A.
    Uemura, T.
    Mizumoto, M.
    Masui, T.
    Mori, A.
    Okajima, H.
    Hiraoka, M.
    Uemoto, S.
    PANCREAS, 2014, 43 (08) : 1376 - 1376
12345